
Therapeutic Review4 min read
COPD Beyond Inhalers
Can biologics reach more patients? IL-33 inhibition may extend exacerbation prevention beyond eosinophil-selected trials, but important questions remain.
Read articleBrowse all Therapeutic Review articles from Medeasy Review.

Can biologics reach more patients? IL-33 inhibition may extend exacerbation prevention beyond eosinophil-selected trials, but important questions remain.
Read article
Where does baxdrostat fit? Key takeaways and clinical pearls.
Read article
Phase 3 evidence for adjuvant ensartinib after complete resection of ALK-positive NSCLC.
Read article